Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study

Autor: Moliterno, David J, Yakubov, Steven J, DiBattiste, Peter M, Herrmann, Howard C, Stone, Gregg W, Macaya, Carlos, Neumann, Franz-Josef, Ardissino, Diego, Bassand, Jean-Pierre, Borzi, Lynn, Yeung, Alan C, Harris, Katherine A, Demopoulos, Laura A, Topol, Eric J
Zdroj: In The Lancet 3 August 2002 360(9330):355-360
Databáze: ScienceDirect
Nepřihlášeným uživatelům se plný text nezobrazuje